Is MaxCyte, Inc. overvalued or undervalued?

Jun 25 2025 08:30 AM IST
share
Share Via
As of March 22, 2022, MaxCyte, Inc. is considered overvalued and rated as risky due to poor financial metrics, including a Price to Book Value of 1.15, an EV to Sales ratio of 2.43, and a negative ROCE of -80.39%, despite performing better than some peers like Scholar Rock in terms of EV to EBITDA.
As of 22 March 2022, the valuation grade for MaxCyte, Inc. moved from does not qualify to risky. The company is currently considered overvalued based on its financial metrics and peer comparisons. Key ratios include a Price to Book Value of 1.15, an EV to Sales ratio of 2.43, and a ROCE of -80.39%.

In comparison to peers, MaxCyte's EV to EBITDA stands at -2.00, while Scholar Rock Holding Corp. has a significantly worse EV to EBITDA of -9.8457, indicating that MaxCyte is not the worst performer in its category. However, the overall financial health remains concerning, especially with a YTD return of -47.84% compared to the S&P 500's 2.44%, reinforcing the notion that the stock is overvalued relative to its performance and industry standing.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is MaxCyte, Inc. technically bullish or bearish?
Sep 20 2025 07:20 PM IST
share
Share Via
Is MaxCyte, Inc. overvalued or undervalued?
Sep 20 2025 05:55 PM IST
share
Share Via
Is MaxCyte, Inc. technically bullish or bearish?
Jun 25 2025 08:27 AM IST
share
Share Via
Who are in the management team of MaxCyte, Inc.?
Jun 22 2025 10:15 PM IST
share
Share Via
What does MaxCyte, Inc. do?
Jun 22 2025 06:16 PM IST
share
Share Via
How big is MaxCyte, Inc.?
Jun 22 2025 05:42 PM IST
share
Share Via